サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1631470

精神科デジタルバイオマーカーの市場規模、シェア、動向分析レポート：タイプ別、臨床実践別、最終用途別、地域別、セグメント予測、2025年～2030年

Psychiatric Digital Biomarkers Market Size, Share & Trends Analysis Report By Type, By Clinical Practice, By End-use, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
精神科デジタルバイオマーカーの市場規模、シェア、動向分析レポート：タイプ別、臨床実践別、最終用途別、地域別、セグメント予測、2025年～2030年
出版日: 2024年12月16日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

精神科デジタルバイオマーカー市場動向

世界の精神科デジタルバイオマーカー市場規模は2024年に6億3,129万米ドルとなり、2025～2030年にかけてCAGR 24.35％で成長すると予測されています。

精神疾患の有病率の増加、デジタルヘルス技術の進歩、個別化医療に対する需要の高まりが、精神科デジタルバイオマーカー市場を牽引しています。メンタル医療におけるウェアラブルデバイスとモバイルヘルスアプリの採用増加も市場成長に寄与しています。2024年4月、Sensorsは、デジタル表現型分類が神経疾患に与える影響に関するレビューを発表し、遠隔医療とセンサ技術を通じて臨床検査を改良し、早期発見とモニタリングを支援する可能性を示しました。

うつ病、不安障害、双極性障害、統合失調症などの精神疾患は、世界中で数百万人に影響を及ぼしています。2023年にMental Health America, Incが発表したところによると、12～17歳の青少年の20.17％が大うつ病エピソードに遭遇しており、15％が日常生活に影響を及ぼす深刻な障害に苦しんでいます。このような有病率の増加は、メンタルヘルス状態をモニタリング・管理するためのより効果的なツールの必要性を促し、精神科デジタルバイオマーカーへの関心の高まりにつながっています。2022年7月、Pervasive and Mobile Computing誌は、うつ病患者と非うつ病患者の間で、気分とデジタルマーカー（睡眠や電話の使用状況など）に有意差があることを示す調査結果を発表しました。また、これらのデジタルバイオマーカーを単独で、あるいは気分の評価と組み合わせることで、うつ病の状態を正確に予測できることも確認されました。

デジタルヘルス技術の技術的進歩は、メンタルヘルスのセグメントに革命をもたらします。人工知能（AI）、機械学習、データ分析などの技術革新により、個人のメンタルヘルス状態に関する貴重な洞察を提供する先進的デジタルバイオマーカーの開発が可能になりました。AIを搭載したアルゴリズムは、スマートフォンのセンサからのデータを分析し、メンタルヘルス危機の初期兆候を示す行動パターンの変化を検出します。2023年11月、『Frontiers in Psychiatry』誌の記事は、気分障害の予測と管理におけるデジタルバイオマーカーの可能性を強調し、スマートフォンのデータでうつ病と治療反応をモニタリングできること、ウェアラブルデバイスで実世界の環境において気分障害をより正確に追跡できること、AIの進歩で新たな診断と治療の道が開かれつつあることを指摘しました。

医療提供者が個々の患者のニーズに合わせて治療計画を立てようとするため、メンタル医療では個別化医療の需要が高まっています。精神科デジタルバイオマーカーは、患者の症状や治療反応に関する客観的データを提供することで、個別化介入を可能にする上で重要な役割を果たしています。ウェアラブルデバイスやモバイルヘルスアプリの普及が進むにつれ、従来の臨床環境以外でも患者の継続的なモニタリングが可能になり、この動向はさらに加速しています。2022年3月、DTU Health Techの研究開発者は、音声分析を用いて個人の双極性障害を特定し、患者の気分の変化をモニターする方法を開発しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 精神科デジタルバイオマーカー市場の変数、動向、範囲

  • 市場系統の展望
    • 親市場の展望
    • 関連/補助的な市場展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 精神科デジタルバイオマーカー市場分析ツール
    • 産業分析-ポーターのファイブフォース分析
    • PESTEL分析

第4章 精神科デジタルバイオマーカー市場：タイプ別、推定・動向分析

  • セグメントダッシュボード
  • 世界の精神科デジタルバイオマーカー市場のタイプ変動分析
  • 世界の精神科デジタルバイオマーカー市場規模と動向分析、タイプ別、2018～2030年
  • ウェアラブル
  • モバイルベース用途
  • センサ
  • その他

第5章 精神科デジタルバイオマーカー市場：臨床実践別、推定・動向分析

  • セグメントダッシュボード
  • 世界の精神科デジタルバイオマーカー市場の臨床実践変動分析
  • 世界の精神科デジタルバイオマーカー市場規模と動向分析、臨床実践別、2018～2030年
  • 診断精神医療デジタルバイオマーカー
  • 精神医療デジタルバイオマーカーのモニタリング
  • 精神疾患の予測と予後を予測するデジタルバイオマーカー
  • その他（安全性、薬力学/反応、感受性）

第6章 精神科デジタルバイオマーカー市場：最終用途別、推定・動向分析

  • セグメントダッシュボード
  • 世界の精神科デジタルバイオマーカー市場の最終用途変動分析
  • 世界の精神科デジタルバイオマーカー市場規模と動向分析、最終用途別、2018～2030年
  • 医療企業
  • 医療提供者
  • 支払者
  • その他（患者、介護者）

第7章 精神科デジタルバイオマーカー市場：地域別、推定・動向分析

  • 地域別市場シェア分析、2023年と2030年
  • 地域別市場ダッシュボード
  • 市場規模、予測動向分析、2018～2030年
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 企業/競合の分類
  • 戦略マッピング
  • 企業市況分析、2023年
  • 企業プロファイル/上場企業
    • Koneksa
    • Biogen Inc.
    • Empatica Inc.
    • Vivo Sense
    • IXICO plc
    • Huma
    • Sonde Health, Inc.
    • Clario
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global psychiatric digital biomarkers market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 4 Global psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 5 Global psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 6 North America psychiatric digital biomarkers market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 8 North America psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 9 North America psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 10 U.S. psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 11 U.S. psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 12 U.S. psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Canada psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 14 Canada psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 15 Canada psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Mexico psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 17 Mexico psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 18 Mexico psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe psychiatric digital biomarkers market, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 21 Europe psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 22 Europe psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Germany psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 24 Germany psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 25 Germany psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 26 UK psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 27 UK psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 28 UK psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 29 France psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 30 France psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 31 France psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Italy psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 33 Italy psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 34 Italy psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Spain psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 36 Spain psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 37 Spain psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Denmark psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 39 Denmark psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 40 Denmark psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Sweden psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 42 Sweden psychiatric digital biomarkers market, by clinical practice, 2018-2030, (USD Million
  • Table 43 Sweden psychiatric digital biomarkers market, by end use, 2018-2030, (USD Million
  • Table 44 Norway psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 45 Norway psychiatric digital biomarkers market, by clinical practice, 2018-2030, (USD Million
  • Table 46 Norway psychiatric digital biomarkers market, by end use, 2018-2030, (USD Million
  • Table 47 Asia Pacific psychiatric digital biomarkers market, by country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific psychiatric digital biomarkers market, by clinical practice, 2018-2030, (USD Million
  • Table 50 Asia Pacific psychiatric digital biomarkers market, by end use, 2018-2030, (USD Million
  • Table 51 China psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 52 China psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 53 China psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Japan psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 55 Japan psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 56 Japan psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 57 India psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 58 India psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 59 India psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 60 South Korea psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 61 South Korea psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 62 South Korea psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 63 Australia psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 64 Australia psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 65 Australia psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Thailand psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 67 Thailand psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 68 Thailand psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Latin America psychiatric digital biomarkers market, by country, 2018 - 2030 (USD Million)
  • Table 70 Latin America psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 71 Latin America psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 72 Latin America psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Brazil psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 74 Brazil psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 75 Brazil psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Argentina psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 77 Argentina psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 78 Argentina psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 79 MEA psychiatric digital biomarkers market, by country, 2018 - 2030 (USD Million)
  • Table 80 MEA psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 81 MEA psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 82 MEA psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 83 South Africa psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 84 South Africa psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 85 South Africa psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 89 UAE psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 90 UAE psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 91 UAE psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 92 Kuwait psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 93 Kuwait psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 94 Kuwait psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Psychiatric digital biomarkers market: Market outlook
  • Fig. 5 Psychiatric digital biomarkers market: Segment outlook
  • Fig. 6 Psychiatric digital biomarkers market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Psychiatric digital biomarkers market driver impact
  • Fig. 9 Psychiatric digital biomarkers market restraint impact
  • Fig. 10 Psychiatric digital biomarkers market: Type outlook and key takeaways
  • Fig. 11 Psychiatric digital biomarkers market: Type movement analysis
  • Fig. 12 Wearable market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 13 Mobile based applications market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 14 Sensors market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Psychiatric digital biomarkers market: Clinical Practice outlook and key takeaways
  • Fig. 17 Psychiatric digital biomarkers market: Clinical Practice movement analysis
  • Fig. 18 Diagnostic psychiatric digital biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Monitoring psychiatric digital biomarkers market estimates and forecast, 2018-2030, (USD Million
  • Fig. 20 Predictive and prognostic psychiatric digital biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Other's (safety, pharmacodynamics/ response, susceptibility) market estimates and forecast, 2018-2030, (USD Million
  • Fig. 22 Psychiatric digital biomarkers market: End Use outlook and key takeaways
  • Fig. 23 Psychiatric digital biomarkers market: End Use movement analysis
  • Fig. 24 Healthcare companies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Healthcare providers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Payers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Global psychiatric digital biomarkers market: Regional outlook and key takeaways
  • Fig. 29 Global psychiatric digital biomarkers market: Regional movement analysis
  • Fig. 30 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68040-367-6

Psychiatric Digital Biomarkers Market Trends:

The global psychiatric digital biomarkers market size was valued at USD 631.29 million in 2024 and is projected to grow at a CAGR of 24.35% from 2025 to 2030. Increasing prevalence of mental health disorders, advancements in digital health technologies and growing demand for personalized medicine drive the psychiatric digital biomarkers market. Rising adoption of wearable devices and mobile health apps in mental healthcare contribute to the market growth. In April 2024, Sensors published a review on digital phenotyping's impact on neurological diseases, showing its potential to refine clinical trials and aid in early detection and monitoring through telemedicine and sensor technologies.

The global burden of mental health disorders is on the rise, with conditions such as depression, anxiety, bipolar disorder, and schizophrenia affecting millions of people worldwide. In 2023, Mental Health America, Inc found that 20.17% of youths aged 12-17 had encountered a major depressive episode, with 15% suffering severe impairment affecting daily activities. This increasing prevalence is driving the need for more effective tools to monitor and manage mental health conditions, leading to a growing interest in psychiatric digital biomarkers. In July 2022, Pervasive and Mobile Computing published findings showing significant differences in mood and digital markers (such as sleep and phone usage) between depressed and non-depressed individuals. It also confirmed that depression status could be accurately predicted using these digital biomarkers alone or combined with mood ratings.

Technological advancements in digital health technologies revolutionize the field of mental healthcare. Innovations such as artificial intelligence (AI), machine learning, and data analytics enable the development of sophisticated digital biomarkers that provide valuable insights into an individual's mental health status. AI-powered algorithms analyze data from smartphone sensors to detect changes in behavior patterns that indicate early signs of a mental health crisis. In November 2023, an article in Frontiers in Psychiatry highlighted the potential of digital biomarkers in predicting and managing mood disorders, noting how smartphone data can monitor depression and treatment responses, wearable devices can track mood disorders more accurately in real-world settings, and AI advancements are opening up new diagnostic and therapeutic avenues.

There is a growing demand for personalized medicine in mental healthcare, as healthcare providers seek to tailor treatment plans to individual patients' needs. Psychiatric digital biomarkers play a crucial role in enabling personalized interventions by providing objective data on patients' symptoms and treatment responses. The increasing adoption of wearable devices and mobile health apps further fuels this trend, allowing for continuous monitoring of patients outside traditional clinical settings. In March 2022, DTU Health Tech researchers developed a method using voice analysis to identify bipolar disorder in individuals and monitor mood changes in patients, with personalized models providing the most accurate results.

Global Psychiatric Digital Biomarkers Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global psychiatric digital biomarkers market report based on type, clinical practice, end-use, and region.

  • Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Wearable
  • Mobile based Applications
  • Sensors
  • Others
  • Clinical Practice Outlook (Revenue, USD Million, 2018 - 2030)
  • Diagnostic Psychiatric Digital Biomarkers
  • Monitoring Psychiatric Digital Biomarkers
  • Predictive and Prognostic Psychiatric Digital Biomarkers
  • Other's (Safety, Pharmacodynamics/ Response, Susceptibility)
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Healthcare companies
  • Healthcare Providers
  • Payers
  • Others (Patient, caregivers)
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Type
    • 1.2.2. Clinical Practice
    • 1.2.3. End Use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Psychiatric Digital Biomarkers Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of mental health disorders,
      • 3.2.1.2. Advancements in digital health technologies
      • 3.2.1.3. Growing demand for personalized medicine
      • 3.2.1.4. Rising adoption of wearable devices and mobile health apps
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Regulatory hurdles
  • 3.3. Psychiatric Digital Biomarkers Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. Psychiatric Digital Biomarkers Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Psychiatric Digital Biomarkers Market Type Movement Analysis
  • 4.3. Global Psychiatric Digital Biomarkers Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Wearable
    • 4.4.1. Wearable market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Mobile based Applications
    • 4.5.1. Mobile based applications market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Sensors
    • 4.6.1. Sensors market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Psychiatric Digital Biomarkers Market: Clinical Practice Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Psychiatric Digital Biomarkers Market Clinical Practice Movement Analysis
  • 5.3. Global Psychiatric Digital Biomarkers Market Size & Trend Analysis, by Clinical Practice, 2018 to 2030 (USD Million)
  • 5.4. Diagnostic Psychiatric Digital Biomarkers
    • 5.4.1. Diagnostic psychiatric digital biomarkers market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Monitoring Psychiatric Digital Biomarkers
    • 5.5.1. Monitoring psychiatric digital biomarkers market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Predictive and Prognostic Psychiatric Digital Biomarkers
    • 5.6.1. Predictive and prognostic psychiatric digital biomarkers market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Other's (Safety, Pharmacodynamics/ Response, Susceptibility)
    • 5.7.1. Other's (safety, pharmacodynamics/ response, susceptibility) market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Psychiatric Digital Biomarkers Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Psychiatric Digital Biomarkers Market End Use Movement Analysis
  • 6.3. Global Psychiatric Digital Biomarkers Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Healthcare Companies
    • 6.4.1. Healthcare companies market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Healthcare Providers
    • 6.5.1. Healthcare providers market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Payers
    • 6.6.1. Payers market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Others (Patient, Caregivers)
    • 6.7.1. Others (patient, caregivers) market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Psychiatric Digital Biomarkers Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. Mexico
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. UK
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Germany
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. France
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Italy
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. Spain
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Norway
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Regulatory framework
      • 7.5.8.3. Competitive scenario
      • 7.5.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. India
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Australia
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Thailand
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Argentina
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. South Africa
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.3. UAE
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.4. Kuwait
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Regulatory framework
      • 7.8.4.3. Competitive scenario
      • 7.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2023
  • 8.4. Company Profiles/Listing
    • 8.4.1. Koneksa
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Type benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Biogen Inc.
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Type benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Empatica Inc.
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Type benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Vivo Sense
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Type benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. IXICO plc
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Type benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Huma
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Type benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Sonde Health, Inc.
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Type benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Clario
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Type benchmarking
      • 8.4.8.4. Strategic initiatives